ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 57

Genetic Polymorphism of IL-1RN Encoding the IL-1 Receptor Antagonist Predicts Radiographic Severity of Symptomatic Knee OA

Mukundan Attur1, Sisi Ma2, Jonathan Samuels3, Svetlana Krasnokutsky Samuels4, Hua Zhou2, Jenny Bencardino5, Marc C. Hochberg6, Braxton Mitchell7, Virginia B. Kraus8, Joanne M. Jordan9 and Steven B. Abramson10, 1Rheumatology Research, NYU - Hospital for Joint Diseases, New York, NY, 2Bioinformatics, New York University, New York, NY, 3Rheumatology, NYU - Hospital for Joint Diseases, New York, NY, 4Medicine/Rheumatology, NYU School of Medicine/NYU Hospital for Joint Diseases, New York, NY, 5Radiology, NYU Langone Medical Center, New York, NY, 6University of Maryland School of Medicine, Baltimore, MD, USA, Baltimore, MD, 7Departments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD, 8Department of Medicine, Duke University Medical Center, Durham, NC, 9Thurston Arthritis Research Center, University of North CArolina at Chapel Hill, Chapel Hill, NC, 10Dept of Rheumatology/Medicine, Hosp for Joint Diseases/NYU, New York, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: genetics, Osteoarthritis, radiography and severity

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Genetics, Genomics and Proteomics - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Growing numbers of studies show increased expression in Osteoarthritis (OA) of inflammatory cytokines, such as IL-1β and TNFα, in joint tissues and peripheral blood mononuclear (PBM) cells. The IL1 receptor antagonist (IL1RN) gene cluster region has been associated with susceptibility to knee OA, thereby further implicating inflammation in OA pathogenesis. In these studies, we examined the association of IL-1RN haplotype with the radiographic severity of symptomatic knee OA (SKOA).

Methods: Genomic DNA from SKOA patients from three cohorts (NYU I, NYU-II and OAI – clinical characteristics are described in Table 1) in this prospective analysis were used to genotype three single nucleotide polymorphisms (SNPs) [rs419598, rs315952 & rs9005) based on our prior publications. Genotyping was accomplished by PCR using validated SNP primers and probes (Applied Biosystems) along with detection using allelic discrimination computation. Genotypes were scored blinded to all patients’ data. Statistical analyses for associations of genotype with OA radiographic severity used Chi square and Fisher’s exact test, with linear regression, adjusting for age, gender and BMI. Non-fasting Heparin plasma IL-1Ra levels were determined using R&D system ELISA kit.

Results: Carriage of two copies of a haplotype consisting of IL1RN rs419598, IL1RN rs315952 and IL1RN rs9005 (TTG-2), had a population frequency of 18%, and was associated with a significantly increased risk of more severe radiographic SKOA (KL1-2 vs. KL3/4; OR > 3.07; 95% CI 1.67 -5.68; p=0.000), compared to SKOA patients with zero copies of TTG (TTG-0) in all three cohorts (Table 1). Furthermore, narrower baseline radiographic medial joint space width (mJSW) was similarly associated with TTG-2 haplotype (Table 2). TTG-2 patients exhibited decreased JSW compared to TTG-0 patients of comparable age (50-80 years), consistent with earlier onset of disease. Biologically, TTG-2 patients in two of the cohorts had reduced plasma concentrations of the “protective” IL1RN gene product, IL-1Ra, (297 to 338 pg/ml; p=0.14) relative to TTG-0 OA patients.

Conclusion: IL-1RN haplotype TTG (rs9005, rs419598 and rs315952) predicted high risk for greater severity of radiographic knee OA. Carriers of two copies of the TTG SNP also exhibited lower plasma IL-1Ra concentrations. These data are consistent with the hypothesis that a relative deficiency of IL-Ra typified by TTG-2 patients results in enhanced IL-1β action in joint tissues and more severe OA. These genetic markers may also be useful as tools for enriching OA clinical trials for disease progressors.   Table 1: Baseline Clinical Characteristics and Association of IL-1RN Haplotype (TTG) With Radiographic Severity In Symptomatic Knee OA Patients  

Mean (SD)

OA Severity   (KL1/2 vs. KL3/4)  
IL-1RN Haplotype (TTG) Cohorts (N=612) Gender % Female Age BMI VAS pain NRS pain mJSW (mm) Odds ratio (95% CI) p value
rs41958, rs315952, rs9005 NYU-I (146) 61.64 62.46 (10.11) 26.62 (3.58) 41.70 (28.30) N/A 3.26 (1.75) 5.38 (1.25 – 23.28) 0.024
NYU-II (226) 63.72 60.42 (10.68) 26.20 (3.45) N/A N/A 3.18 (1.31) 4.19 (1.35 – 13.01) 0.016
OAI (240) 62.08 61.96 (8.90) 30.35 (5.09) N/A 6.36 (1.60) 3.48 (1.7) 2.26 (0.90 – 5.70) 0.107
All three cohorts combined             3.07 (1.67 – 5.68) 0.0003

Table 2: Association of IL-1RN Haplotype (TTG) With Baseline Radiographic Medial Joint Space Width (mJSW) In Symptomatic Knee OA Patients

  TTG ( 0 copies) TTG ( 2 copies)  
IL-1RN Haplotype (TTG) Cohorts Mean JSW (SD) in mm Mean JSW (SD) in mm p value
rs41958, rs315952, rs9005 NYU-I

3.62 (1.681)

2.51 (1.66)

0.013

NYU-II

3.31 (1.25)

2.68 (1.75)

0.074

OAI

3.82 (1.43)

3.18 (1.24)

0.094

All three cohorts combined

3.52 (1.43)

2.92 (1.82)

0.005

       


Disclosure: M. Attur, Interleukin Genetics, Inc., 7; S. Ma, None; J. Samuels, None; S. Krasnokutsky Samuels, None; H. Zhou, None; J. Bencardino, None; M. C. Hochberg, None; B. Mitchell, None; V. B. Kraus, None; J. M. Jordan, None; S. B. Abramson, Interleukin Genetics, Inc., 7.

To cite this abstract in AMA style:

Attur M, Ma S, Samuels J, Krasnokutsky Samuels S, Zhou H, Bencardino J, Hochberg MC, Mitchell B, Kraus VB, Jordan JM, Abramson SB. Genetic Polymorphism of IL-1RN Encoding the IL-1 Receptor Antagonist Predicts Radiographic Severity of Symptomatic Knee OA [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/genetic-polymorphism-of-il-1rn-encoding-the-il-1-receptor-antagonist-predicts-radiographic-severity-of-symptomatic-knee-oa/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-polymorphism-of-il-1rn-encoding-the-il-1-receptor-antagonist-predicts-radiographic-severity-of-symptomatic-knee-oa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology